Overview

Kaletra Sex/Gender Pharmacokinetics (PK) Study

Status:
Completed

Trial end date:
2007-01-01

Target enrollment:

Participant gender:

Summary

The levels of lopinavir achieved in the blood following oral ingestion of standard doses of Kaletra (lopinavir/ritonavir) in HIV-infected men was compared with those achieved in HIV-infected women receiving the same dose of the drug.

Phase:

Phase 4

Details

Lead Sponsor:

Emory University

Collaborator:

Abbott

Treatments:

Lopinavir
Ritonavir